The GEO Group (GEO) – Amends Senior Revolving Credit Facility


Wednesday, July 16, 2025

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO’s diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care®, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO’s worldwide operations include the ownership and/or delivery of support services for 103 facilities totaling approximately 83,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Amended Facility. The GEO Group announced amendments to its April 2024 Credit Agreement that provide enhanced flexibility, better terms, and an extended maturity. Along with the additional payments on the outstanding debt, GEO has taken another step closer to being able to return capital to shareholders, in our view.

Details. The Amendment increases GEO’s revolver commitments from $310 million to $450 million and extends the maturity to July 14, 2030. The Amendment further provides that interest will accrue on outstanding revolving credit loans at a rate determined with reference to the Company’s total leverage ratio, which, as of today, reduces the rate by 0.50% from the prior applicable rate. The Amendment also increases GEO’s capacity to make restricted payments over the next five years.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

SelectQuote (SLQT) – Temporary Pressure, Strong Path Forward


Wednesday, July 16, 2025

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Setting up fiscal 2026. We are adjusting our fiscal Q4 estimates to reflect updated expectations for the Medicare Advantage market, with a particular focus on recent regulatory changes affecting Special Needs Plans (SNPs). While these developments introduce near-term challenges, we believe SelectQuote is well-positioned heading into fiscal 2026. We expect the company to rebuild agent capacity ahead of the next Annual Enrollment Period (AEP), to support a trajectory of sustained revenue growth and adj. EBITDA margin expansion.

Special Needs changes. Our revised Q4 outlook is primarily driven by recent changes implemented by CMS that restructure Special Needs Plan switching rights. The policy shift narrows mid-year enrollment flexibility for a significant portion of dual-eligible consumers (those enrolled in non-integrated D-SNPs), leading to the prospect of a smaller pool of shopping beneficiaries during the middle of calendar 2025. In addition, we are accounting for SelectQuote’s reduced year-over-year agent count, which entered fiscal 2025 approximately 22% below the prior-year level due to capital constraints at the time. These factors combined create a more muted backdrop for near-term Medicare Advantage performance.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Hemisphere Energy (HMENF) – Extending a Track Record of Returning Capital to Shareholders


Wednesday, July 16, 2025

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Special dividend. Hemisphere Energy declared a special dividend of C$0.03 per common share that is payable on August 15 to shareholders of record as of July 31. It is in addition to the company’s quarterly base dividend of C$0.025 per common share and is Hemisphere’s second special dividend payment in 2025.

Normal course issuer bid. Hemisphere Energy recently announced that the TSX Venture Exchange had accepted its notice to renew its Normal Course Issuer Bid (NCIB) to purchase for cancellation up to 7,934,731 common shares. Purchases will be made on the open market at prevailing market prices through the TSXV. The NCIB commenced on July 14, 2025, and will terminate on July 13, 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Breakthrough in Type 1 Diabetes: Stem Cell-Derived Islets Offer Hope for a Cure

In a major milestone for type 1 diabetes treatment, a groundbreaking clinical trial has shown that stem cell-derived islet cell transplantation can effectively eliminate the need for insulin in patients. This advancement marks a turning point in diabetes care and highlights the efforts of leading researchers, including Dr. Piotr Witkowski at the University of Chicago, and the collaborative work of Vertex Pharmaceuticals (VRTX) and Eledon Pharmaceuticals (ELDN).

Historically, islet cell transplantation involved harvesting pancreatic islets from deceased organ donors—a limited and logistically challenging source. Patients often required multiple transplants to see long-term benefits, and donor scarcity severely limited access to the therapy. But now, lab-manufactured islets derived from stem cells are changing the game, offering a consistent, scalable, and potentially off-the-shelf solution to treating the most severe forms of type 1 diabetes.

In the ongoing multicenter clinical trial, presented at the American Diabetes Association’s Scientific Sessions and published in the New England Journal of Medicine, 10 of 12 patients remained insulin-independent for over a year after just a single infusion of stem cell-derived islets. This level of success, particularly from a single dose, is unprecedented in the field and demonstrates the power of scientific innovation to transform chronic disease management.

Dr. Witkowski, a lead investigator and transplant surgeon at the University of Chicago, has been at the forefront of this effort. His involvement traces back to the early development of the clinical protocol in 2019 with Andrea Vergani at Semma Therapeutics. After Vertex Pharmaceuticals acquired Semma, Dr. Witkowski continued his work as a member of the Scientific Advisory Board and as a principal investigator performing transplants. As of last week, his team has successfully infused their 10th patient with Vertex’s stem cell-derived islets.

While these results are promising, patients receiving the treatment still require immunosuppressive therapy to prevent rejection—typically involving drugs like tacrolimus, which can be toxic over time. That’s where Eledon Pharmaceuticals (ELDN) enters the picture. In a parallel pilot study, researchers are evaluating Tegoprubart, Eledon’s novel immunosuppressive agent designed to reduce toxicity while maintaining immune protection. If successful, Tegoprubart could offer a safer path forward and expand access to islet transplantation for a broader population.

The future is bright. Trials are now underway to test the therapy in kidney transplant recipients—patients already on immunosuppressants—providing an ideal setting to further prove the therapy’s safety and effectiveness. With continued success, stem cell-derived islets could soon become a standard-of-care treatment, immediately benefitting the 40,000+ patients in the U.S. suffering from the most unmanageable forms of diabetes.

Thanks to the visionary work of scientists, clinicians, and companies like Vertex and Eledon, what was once a highly experimental and limited therapy is on track to become a scalable medical solution. As Dr. Piotr Witkowski and his team continue their work, the path to a functional cure for type 1 diabetes is finally within reach.

Learn more about Eledon Pharmaceuticals here.

AngloGold Ashanti to Acquire Augusta Gold, Strengthening Its Hold in Nevada’s Beatty District

AngloGold Ashanti has announced a definitive agreement to acquire Augusta Gold Corp. in a deal valued at approximately C$152 million (US$111 million), marking a strategic move to consolidate its footprint in the Beatty District of Nevada—one of the most promising gold regions in North America.

The all-cash transaction offers C$1.70 per share to Augusta Gold shareholders, representing a 28% premium over the company’s July 15 closing price and a 37% premium over its 20-day volume-weighted average. The acquisition also includes the repayment of shareholder loans amounting to US$32.6 million as of March 31, 2025.

AngloGold Ashanti’s acquisition of Augusta Gold is aimed at bolstering its development plans in the Beatty District. The deal includes Augusta Gold’s key assets—namely the Reward and Bullfrog projects, both adjacent to AngloGold Ashanti’s existing land holdings.

“This acquisition reinforces the value we see in one of North America’s most prolific gold districts,” said Alberto Calderon, CEO of AngloGold Ashanti. “It strengthens our ability to plan and develop this region under an integrated strategy—streamlining operations, improving infrastructure access, and enhancing stakeholder collaboration.”

The Reward project is a permitted, feasibility-stage asset, while the Bullfrog deposit brings significant additional mineral resources. The acquired properties also come with surrounding tenements, further expanding AngloGold’s regional influence.

Under the agreement, Augusta Gold will become an indirect, wholly owned subsidiary of AngloGold Ashanti. Upon closing, its shares will be delisted from public exchanges and cease trading over-the-counter.

The deal has received unanimous approval from Augusta Gold’s board of directors and its audit committee. Furthermore, key shareholders—representing approximately 31.5% of Augusta’s outstanding stock—have signed voting support agreements to approve the merger.

The transaction is expected to close in the fourth quarter of 2025, pending standard regulatory and shareholder approvals. Augusta Gold will seek approval from a majority of shareholders, excluding related parties, at a special meeting later this year.

AngloGold Ashanti is working with RBC Capital Markets as financial advisor, with legal counsel provided by Womble Bond Dickinson (US) LLP, Cravath, Swaine & Moore LLP in the U.S., and Stikeman Elliott LLP in Canada.

Headquartered in Denver, AngloGold Ashanti is a leading global gold mining company with operations, projects, and exploration activities across ten countries on four continents. The company’s expansion in the U.S. through strategic acquisitions is part of its broader plan to enhance production capabilities and resource access in high-potential districts.

As the Beatty District emerges as a critical gold hub, this acquisition marks a significant milestone for AngloGold Ashanti. By integrating Augusta Gold’s assets, the company aims to unlock further value in the region, streamline its development efforts, and reinforce its status as a dominant force in North American gold mining.

Lucky Strike Entertainment (LUCK) – A Compelling Transaction


Tuesday, July 15, 2025

Lucky Strike Entertainment is one of the world’s premier location-based entertainment platforms. With over 360 locations across North America, Lucky Strike Entertainment provides experiential offerings in bowling, amusements, water parks, and family entertainment centers. The company also owns the Professional Bowlers Association, the major league of bowling and a growing media property that boasts millions of fans around the globe. For more information on Lucky Strike Entertainment, please visit ir.luckystrikeent.com.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Purchases real estate. The company announced that it purchased the real estate of 58 existing bowling centers for $306 million from Carlyle Group, its main sale leaseback partner. The real estate is located in California, Illinois, Georgia, Arizona, and Colorado. With the purchase, the company now owns roughly 75 of its over 350 bowling centers. 

Financing set. The company amended its existing credit facility to provide a bridge loan of $230 million towards the purchase. Cash was used for the remaining purchase amount. We believe that the company will reduce the bridge loan over the course of the next year through free cash flow generation. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Inflation Ticks Up in June as Tariffs and Essentials Drive Prices Higher

U.S. consumers felt a noticeable pinch in June as inflation climbed to 2.7% annually, up from 2.4% in May. With global trade tensions escalating and new tariffs on imports taking effect, everyday essentials like food, healthcare, and shelter are becoming more expensive—leaving many Americans bracing for what’s next.

The latest Consumer Price Index (CPI) report, released Tuesday, signals that inflationary pressures remain persistent despite previous signs of cooling. While prices for airfare and automobiles—both new and used—eased slightly, other critical categories saw continued increases.

One key concern behind June’s uptick: the return of global trade tariffs. Analysts point to rising prices in categories that are closely tied to international trade, such as furniture, appliances, and clothing. Household furnishings, for example, jumped 1% in June—the sharpest increase since early 2022—suggesting that tariffs are starting to filter through to consumer prices.

Recreation and apparel costs also edged higher, adding to speculation that the economic fallout from tariffs may only be getting started.

Food inflation continues to strain household budgets. Grocery prices rose another 0.3% in June, matching May’s increase and marking a 2.4% year-over-year rise. Meat prices, particularly beef, have remained stubbornly high. Ground beef now averages $6.10 per pound—nearly 10% more than this time last year. Steak prices soared even higher, with a 12.4% annual jump.

While egg prices have finally begun to fall—dropping 7.4% from May—their average price of $3.78 per dozen remains significantly higher than the $2.72 average just a year ago. Eating out also became more expensive, with restaurant prices climbing 0.4% in June and up 3.8% year-over-year.

Healthcare costs continue to rise at a steady pace. Medical services were up 0.6% from May and 3.4% from a year ago. Hospital services and nursing home care saw even larger increases, at 4.2% and 5.1% respectively. Health insurance premiums also edged higher, up 3.4% from last year.

Shelter costs—typically the largest portion of household expenses—rose another 0.2% last month and are now 3.8% higher than June 2024. However, increased apartment construction and cooling home prices may offer a slight reprieve in coming months.

There was at least one bright spot for consumers: gasoline. Prices at the pump rose 1% in June but remain 8.3% lower than a year ago. AAA reports a national average of $3.15 per gallon, down from $3.52 last summer.

Used car prices dipped 0.7% monthly, and new vehicle prices fell 0.3%—further signaling stabilization after pandemic-era surges.

With inflation still above the Federal Reserve’s 2% target, economists expect the central bank to keep interest rates unchanged at its July meeting. The hotter-than-expected June data may also delay hopes for a rate cut in September.

For now, households are being forced to navigate a landscape where necessities cost more and relief remains limited—especially if tariffs continue to ripple through the economy.

Zimmer Biomet Acquires Monogram Technologies to Lead in Robotic Orthopedics

Zimmer Biomet (NYSE: ZBH), one of the world’s leading medical technology companies, announced a definitive agreement to acquire Monogram Technologies (NASDAQ: MGRM), a fast-growing robotics innovator, in a strategic move that could redefine the future of orthopedic surgery. The $177 million all-cash deal includes an upfront payment of $4.04 per share and a potential additional $12.37 per share via a non-tradeable contingent value right (CVR), contingent on milestones through 2030.

The acquisition marks a major milestone in Zimmer Biomet’s mission to deliver a next-generation surgical robotics platform. Monogram brings proprietary semi- and fully autonomous robotic systems designed for total knee arthroplasty (TKA), bolstered by FDA clearance in early 2025. The deal also positions Zimmer Biomet to be the first company in orthopedics to offer a fully autonomous surgical robot—a potential game-changer in an increasingly tech-driven sector.

Zimmer Biomet’s existing ROSA® Robotics platform already leads in imageless robotics and is nearing 2,000 global installations. By integrating Monogram’s AI-driven, CT-based surgical systems, the company expands its portfolio to address varying surgeon preferences—manual, semi-autonomous, or fully autonomous—and across different anatomical procedures.

This acquisition gives Zimmer Biomet a first-mover advantage in the race for orthopedic robotics innovation. With Monogram’s platform, the company aims to deliver safer, more efficient surgeries and drive adoption across hospitals and ambulatory surgery centers (ASCs) seeking digital and robotic enhancements.

Monogram’s technology complements Zimmer Biomet’s current development pipeline, including ROSA Knee with OptimiZe, ROSA Posterior Hip, and ROSA Shoulder—key components of its multi-year plan to remain the global leader in orthopedic robotics.

Financially, the acquisition is expected to be neutral to Zimmer Biomet’s adjusted earnings per share through 2027 and accretive thereafter. Management projects high-single-digit returns on invested capital by year five, fueled by accelerated robotic knee adoption, greater share of wallet, and broader customer reach in the U.S. and internationally.

Tariffs and broader market volatility have weighed on the healthcare sector in 2025, but Zimmer Biomet’s move signals a long-term, innovation-led growth strategy. By enhancing its robotics suite, the company is positioning itself to capture demand in one of the fastest-growing medtech segments.

With regulatory approval and Monogram shareholder consent still pending, the merger is expected to close later this year. Once complete, Zimmer Biomet will be uniquely positioned with the industry’s most flexible and comprehensive orthopedic robotics ecosystem.

This acquisition isn’t just a strategic bolt-on; it’s a forward-looking bet on where surgery is headed—autonomous, data-driven, and personalized. For investors seeking exposure to the convergence of AI, robotics, and healthcare, Zimmer Biomet’s expanding portfolio offers a compelling case for long-term value creation.

Grayscale Files for IPO as Crypto Matures Into Mainstream Finance

Grayscale Investments, one of the most prominent names in digital asset management, has officially begun the process of becoming a publicly traded company. The firm confirmed this week that it confidentially submitted a draft registration statement with the U.S. Securities and Exchange Commission (SEC), signaling its intent to launch an initial public offering (IPO) later this year.

This move arrives amid a resurgence in the cryptocurrency market, with Bitcoin recently climbing above $120,000 for the first time. As institutional adoption deepens and lawmakers advance supportive legislation during what’s being called “Crypto Week” in Washington, the timing of Grayscale’s announcement aligns with a broader wave of investor enthusiasm and regulatory clarity.

Founded in 2013, Grayscale has grown into a cornerstone of the digital asset space. The firm currently manages more than $33 billion in assets and offers over 35 crypto investment products. Among its offerings is a spot Bitcoin ETF that allows investors to gain exposure to Bitcoin price movements without directly holding the underlying asset. This innovation has positioned Grayscale as a leader in connecting traditional investors to the crypto economy.

The decision to file confidentially allows Grayscale to maintain flexibility as it navigates the IPO process. This common strategy enables companies to engage with regulators and fine-tune their offering away from public scrutiny. However, by confirming the filing publicly, Grayscale also sends a clear message: the firm is ready to play on a larger stage.

The IPO comes on the heels of other major crypto firms moving toward public markets. Last month, stablecoin issuer Circle made a splash with a highly successful listing, and Gemini—backed by the Winklevoss twins—has also filed for its own debut. Grayscale’s move further underscores how digital asset firms are maturing beyond the early-adopter phase and entering mainstream finance.

Importantly, Grayscale has already left its mark on financial regulation. The firm played a critical role in paving the way for spot Bitcoin ETFs in the U.S., winning a significant court battle in 2023 that pressured the SEC to approve such products. While its own Grayscale Bitcoin Trust (GBTC) has since been overtaken in size by BlackRock’s lower-fee iShares Bitcoin Trust, Grayscale’s pioneering efforts have helped shape the entire category.

For investors, the potential IPO is not just about a new crypto stock hitting the market. It’s a signal of the asset class’s institutional credibility and long-term staying power. As more corporations and funds add Bitcoin and other digital assets to their balance sheets, and as Congress takes steps toward a clear regulatory framework, companies like Grayscale stand to benefit from both structural tailwinds and investor demand.

While no timeline has been finalized, industry expectations point to a public debut later this year, pending market conditions and regulatory approval. With its deep product suite, brand recognition, and early-mover advantage, Grayscale’s IPO could mark another key milestone in crypto’s journey from fringe finance to Wall Street fixture.

Kratos Defense & Security (KTOS) – Fast Tracked Drone Opportunity; Raising PT


Monday, July 14, 2025

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms, and systems for United States National Security related customers, allies, and commercial enterprises. Kratos is changing the way breakthrough technologies for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.kratosdefense.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Directive. Building on President Trump’s June 6th Executive Order to Unleash American Drone Dominance, this past week Defense Secretary Hegseth signed a memo removing restrictive policies on drone innovation. By leveraging savings from DOGE, the DOD will help power a technological leapfrog and bolster the U.S. drone industry by approving hundreds of made-in-America drone products for purchase by the military. These goals play right into Kratos’ wheelhouse, in our view.

New Focus. The directive focuses on three key areas: strengthening the U.S. drone manufacturing base, arming combat units with a variety of low-cost drones, and ensuring those combat units are well-trained on how to use them. Kratos has been expanding its drone production capabilities, which the recent capital raise will turbocharge. Its drone technology is proven and available today, and the Company is the leader in providing target drones to the military.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

AZZ (AZZ) – Increasing Estimates, Raising PT


Monday, July 14, 2025

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

First quarter financial results. For the first quarter of fiscal year (FY) 2026, AZZ reported adjusted net income of $53.8 million or $1.78 per share compared to $44.0 million or $1.46 per share during the prior year period and our estimate of $50.1 million or $1.66 per share. Compared to the first quarter of FY 2025, sales increased 2.1% to $422.0 million. Adjusted EBITDA increased 13.1% to $106.4 million, representing 25.2% of sales compared to 22.8% of sales during the prior year period.

Updating estimates. We have increased our FY 2026 EBITDA and EPS estimates to $388.3 million and $6.00, respectively, from $381.7 million and $5.83. In FY 2026, our estimates reflect average gross margins of 30.0% and 20.3% for the Metal Coatings and Precoat Metals segments, respectively. Moreover, we have published our estimates for 2027 through 2031 in the back of this report. Our forward estimates reflect an average 30.5% gross margin as a percentage of sales for the Metal Coatings segment, compared to the prior average of 28.0%. The average gross margin as a percentage of sales for the Precoat Metals business is unchanged at 20.3%.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tariff Windfall Pushes U.S. Treasury to Rare Surplus in June

In an unexpected fiscal twist, the U.S. Treasury reported a $27 billion surplus in June — the first time in years the federal government has posted black ink for this particular month. Driving the surprise? A surge in customs duties fueled by newly imposed tariffs under President Donald Trump’s aggressive trade agenda.

The surplus, while modest compared to the year’s broader budget picture, stands in stark contrast to the $316 billion deficit recorded in May. More importantly, it signals how tariff policy is beginning to influence federal revenues in meaningful ways, even as concerns about growing debt and interest costs remain front and center.

The most striking data point from the report was the $27 billion in customs duties collected during June — a 301% increase compared to June 2024. The revenue bump is largely attributed to Trump’s across-the-board 10% tariffs enacted in April, along with a broader set of reciprocal tariffs targeting specific trade partners.

So far this fiscal year, tariff collections have reached $113 billion, an 86% increase year-over-year. These revenues are helping to temporarily offset the impact of broader fiscal challenges, including persistently high debt servicing costs and increased spending in select areas.

This spike in duties comes as negotiations continue with several of America’s largest trading partners. While some sectors — particularly manufacturing and agriculture — have expressed concern about long-term consequences, the short-term impact on federal finances is undeniable.

The June surplus wasn’t only about tariffs. Total federal receipts rose 13% year-over-year, while outlays declined by 7%. Adjusted for calendar shifts, the month would have otherwise shown a $70 billion deficit — still an improvement, but a reminder that structural deficits remain.

Year-to-date, government receipts are up 7%, outpacing the 6% growth in spending. However, the fiscal year deficit still stands at $1.34 trillion with three months remaining, reflecting broader trends that include rising entitlement costs and major legislative spending.

Despite the June surplus, one area of spending continues to cast a long shadow: interest on the national debt. Net interest payments reached $84 billion in June — higher than any other spending category except Social Security. For the fiscal year so far, the U.S. has paid $749 billion in net interest, with projections pointing toward a staggering $1.2 trillion in interest payments by year-end.

These figures highlight the growing burden of servicing the nation’s $36 trillion debt, especially as Treasury yields remain elevated. While Trump has pressured the Federal Reserve to cut interest rates — a move that would help reduce the cost of borrowing — Chair Jerome Powell has signaled caution, particularly given the potential inflationary effects of the new tariffs.

The June surplus provides a rare moment of good news for Washington’s balance sheet, but it may not signal a lasting trend. Much of the improvement stems from one-time revenue boosts and calendar effects. Long-term fiscal stability will still depend on broader policy decisions around spending, entitlement reform, and economic growth.

That said, the recent uptick in tariff-related revenues highlights how trade policy — often viewed primarily through an economic or geopolitical lens — can play an important role in shaping government finances.

If tariff collections continue to surge, they may provide more than just leverage in trade talks — they could also help bridge some of the budget gap. But as with all policy tools, the question remains: at what cost?

Silver’s Perfect Storm: Physical Squeeze Drives Prices to 13-Year Highs

Silver prices surged to their highest level since 2011 this week, fueled by rising premiums in the U.S., tight physical supply in London, and increasing industrial demand. The white metal climbed as high as $37.59 per ounce in the spot market, with U.S. futures contracts pushing toward $38.46—an unusually large gap that signals growing pressure in the global silver supply chain.

This recent rally underscores silver’s unique status as both a monetary asset and a critical industrial material, especially in sectors tied to clean energy. Up more than 27% year-to-date, silver has begun to outpace gold and other precious metals, attracting the attention of traders, long-term investors, and industrial buyers alike.

One of the more telling developments this week is the growing dislocation between the London spot price and U.S. futures contracts. Typically, such discrepancies are short-lived as traders use arbitrage to align prices. But this time, the gap is persisting—indicating logistical constraints and a tightening supply chain.

The root of this premium appears to stem from earlier in the year, when U.S. tariff threats on silver imports spurred a surge in futures prices. That sparked a rush to secure physical metal for delivery to New York’s COMEX warehouses. While the White House later confirmed that bullion would not be exempt from tariffs, the resulting outflow drained accessible inventories.

According to Daniel Ghali of TD Securities, the silver floating in the market is now at record lows. LBMA silver’s free-float has reached its lowest levels in recorded history, with analysts emphasizing that a physical squeeze may be necessary to rebalance the market.

Another warning sign: borrowing costs for silver in London have surged. The one-month implied lease rate jumped to an annualized 4.5% on Friday—well above its usual near-zero levels. This is a clear indicator that silver in London is becoming harder to access, particularly for short sellers and industrial users that rely on short-term lending of physical silver.

Much of London’s silver is held by exchange-traded funds (ETFs), which are not easily available for lending. Bloomberg data shows a 1.1 million ounce inflow into silver-backed ETFs on Thursday alone. While this is good news for long-term investors, it exacerbates near-term scarcity for traders seeking physical delivery.

Silver’s recent surge is also being driven by robust demand from both sides of its identity: as a safe-haven asset and as an industrial input. Its role in clean energy—especially in photovoltaic solar panels—has elevated silver’s strategic importance. According to the Silver Institute, the market is now in its fifth consecutive annual deficit.

As the world pushes further into renewable energy technologies, demand for silver in solar, EVs, and advanced electronics is expected to accelerate.

With inventory levels falling, premiums rising, and industrial demand growing, silver’s bullish outlook appears to be more than a short-term spike. If market dislocations persist and supply tightness continues, silver could enter a new phase of price discovery—driven as much by fundamentals as by financial flows.

Investors would be wise to watch the $40 level as the next psychological milestone. And if the physical squeeze intensifies, we may be entering a new era for this historically underappreciated metal.